Mayne Pharma | MYX - Cost Of Sales



Mayne Pharma reported AUD43.74M in Cost of Sales for its fiscal semester ending in June of 2024.


Cost Of Sales Change Date
Ansell USD 254.1M 232.2M Jun/2024
Avita Medical AUD 2.28M 170K Dec/2024
Cochlear AUD 290.1M 20.2M Dec/2024
CSL USD 3.93B 527M Dec/2024
Healius AUD 107.9M 201.85M Dec/2024
Integral Diagnostics AUD 11.53M 146K Jun/2024
Medical Developments International AUD 5.27M 2.92M Dec/2024
Nanosonics AUD 20.15M 9.46M Dec/2024
Next Science USD 2.1M 172.81K Dec/2024
Polynovo AUD 4.77M 2.77M Jun/2024
Ramsay Health Care AUD 2.23B 6.3M Dec/2024
ResMed USD 518.56M 12.25M Jun/2025
Sigma Healthcare AUD 1.72B 188.07M Jul/2024
Sonic Healthcare AUD 751.66M 801.13M Dec/2024
Telix Pharmaceuticals AUD 148.66M 10.4M Dec/2024